When patients contemplate the multisystemic nature of Ehlers-Danlos Syndrome (EDS)—a group of hereditary connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility—their focus often lands on the joints, the skin, or the cardiovascular system. The larynx, or "voice box," is rarely the primary suspect. However, as the medical community gains a deeper understanding of how connective tissue integrity impacts internal structural stability, a new narrative is emerging: for many living with EDS, the voice is not merely a tool for communication, but a site of persistent, medically significant struggle.
Recent clinical inquiries are shifting the paradigm, suggesting that the "raspy" or "fading" voice frequently dismissed as a byproduct of aging, seasonal allergies, or chronic fatigue may, in fact, be a manifestation of structural instability inherent to EDS.
The Anatomy of the Voice: A Connective Tissue Foundation
To understand why EDS affects the voice, one must first look at the larynx. The vocal folds (vocal cords) are not simple ribbons of muscle; they are complex, multilayered structures composed heavily of collagen and elastin—the very proteins that are structurally compromised in individuals with EDS.
For the human voice to function, the vocal folds must achieve precise, symmetrical closure. They vibrate against one another as air is expelled from the lungs, creating the sound waves that eventually become speech. In an EDS patient, the connective tissue supporting these folds may lack the necessary tensile strength. This can result in vocal folds that are too lax, prone to bowing, or unable to maintain the structural tension required for clear phonation.
Furthermore, the cartilage framework that houses the larynx—the thyroid and cricoid cartilages—relies on dense connective tissue to remain stable. If these cartilaginous structures are hypermobile or improperly supported, the entire mechanism of the voice box can shift, leading to vocal fatigue, breathiness, and a lack of projection.
Chronology of Clinical Discovery
The recognition of voice-related symptoms in the EDS population has been a slow-moving, often anecdotal process that has only recently entered the realm of formal, peer-reviewed clinical research.
- Pre-2020: Voice issues in EDS patients were largely treated as isolated incidents or secondary to comorbidities like Gastroesophageal Reflux Disease (GERD), a condition highly prevalent in the EDS population due to tissue laxity in the esophageal sphincter.
- 2025: A landmark survey conducted by Venkatraman, Schenck, and Thibeault provided the first large-scale quantitative data on the prevalence of vocal symptoms among the EDS community. Their work moved the conversation from speculative to statistical.
- 2026: A scoping review published in the journal Biology consolidated over 15 years of literature, officially identifying structural vocal abnormalities as a recurring feature in clinical cases of EDS, finally bridging the gap between theory and documented pathology.
Supporting Data: The 2025 and 2026 Findings
The landscape of our understanding changed dramatically with the publication of the 2025 survey by Venkatraman et al. The study, which included 437 adults with EDS, revealed that vocal dysfunction is not a rare occurrence; it is a widespread experience.
Of the participants, 400 reported experiencing at least one voice symptom within the previous 12 months. The most frequently reported issues included chronic hoarseness, sudden voice loss, and a significant increase in vocal effort—often referred to as "vocal fatigue." Participants noted that their voices seemed to "tire out" much faster than their peers, particularly after prolonged periods of conversation or in environments with high background noise.
The 2026 scoping review further validated these findings by evaluating 13 distinct studies. The review highlighted that the symptoms are rarely singular. Instead, they often present as a cluster:
- Structural Instability: Laryngeal hypermobility and structural shifting of the cartilaginous framework.
- Functional Impairment: Incomplete glottal closure, which leads to "leaky" voice patterns.
- Compounding Factors: The presence of GERD and Laryngopharyngeal Reflux (LPR) as direct consequences of connective tissue weakness in the digestive tract, which then exacerbates laryngeal inflammation.
While these studies are foundational, researchers emphasize the need for larger, randomized controlled trials. As noted in the 2025 study, individuals experiencing symptoms are statistically more likely to participate in voice-focused research, which could potentially skew the perceived prevalence. Nonetheless, the correlation is too consistent to be ignored.

The Intersection of Comorbidities: Implications for Diagnosis
It is imperative that clinicians and patients do not view vocal changes through a "single-cause" lens. In the EDS population, vocal dysfunction is often a "perfect storm" of biological factors.
The GERD/LPR Connection
One of the most significant implications is the role of the gastrointestinal system. Because EDS affects the connective tissue throughout the body, the esophageal sphincters often lack the tone required to prevent acid from migrating upward. When stomach acid reaches the larynx, it causes inflammation, which creates the very hoarseness that patients attribute to their EDS, not realizing it is a secondary, treatable condition.
Neurological and Muscular Factors
Many EDS patients also experience dysautonomia (such as POTS—Postural Orthostatic Tachycardia Syndrome). The resulting systemic fatigue and altered breathing patterns—often characterized by shallow, thoracic breathing—can deprive the vocal folds of the consistent subglottic air pressure they need to vibrate efficiently.
Clinical Recommendations: Who Can Help?
If you are living with EDS and notice changes in your voice, it is vital to move beyond general practitioners and seek out specialized care. Dismissing these symptoms as "just part of having EDS" can lead to long-term damage, such as vocal nodules or chronic scarring.
- Laryngologists: These are ENT specialists who sub-specialize in the voice. They possess the high-speed imaging equipment necessary to view the vocal folds in motion—a crucial step for identifying structural laxity.
- Speech-Language Pathologists (SLPs): An SLP with experience in hypermobility can design a vocal hygiene and strengthening program that respects the limitations of connective tissue, focusing on compensatory strategies to reduce vocal strain.
- Gastroenterologists: Given the prevalence of reflux, a thorough GI evaluation is often the first step in protecting the larynx from acid-induced damage.
Warning Signs that Require Medical Attention:
- Persistent hoarseness lasting longer than two weeks.
- Sudden or unexplained loss of voice.
- Physical pain when speaking or swallowing.
- Frequent episodes of choking or difficulty managing saliva.
- Shortness of breath that coincides with vocal exertion.
Self-Management and Vocal Hygiene
While professional intervention is critical, there are evidence-based practices that patients can adopt at home to mitigate vocal stress:
- Aggressive Hydration: Because connective tissue in EDS is often dehydrated and fragile, systemic hydration is the first line of defense. Proper hydration ensures that the mucosal lining of the vocal folds remains viscous, allowing for smoother vibration.
- Vocal Pacing and Rest: The "energy envelope" theory applies to the voice just as it does to physical activity. If you know you have a high-demand speaking day, build in periods of "vocal silence."
- Environmental Management: Using humidifiers in the home or office, especially during winter months, can prevent the larynx from drying out, which is a major trigger for hoarseness.
- Allergy Management: Allergies cause swelling in the throat, which forces the vocal folds to work harder to vibrate. Keeping allergy symptoms under control is a critical, yet often overlooked, component of vocal health.
Final Thoughts: The Path Forward
The emergence of research linking Ehlers-Danlos Syndrome to vocal dysfunction marks a significant maturation in our understanding of the disorder. We are moving away from a fragmented view of the body and toward a holistic understanding of how systemic collagen defects manifest in the most subtle, yet essential, functions of human life.
A voice is not merely a sound; it is an identity. When that voice is compromised, the impact on a patient’s professional and social life can be profound. By validating these symptoms, conducting more rigorous clinical research, and fostering interdisciplinary care between rheumatologists, speech pathologists, and laryngologists, we can ensure that patients with EDS are heard—not just in the metaphorical sense, but in the most literal, vocal way possible.
The next phase of EDS research must prioritize the "hidden" symptoms. It is time to treat the voice with the same clinical seriousness as the joints and the heart. After all, every patient deserves to speak with clarity, strength, and ease.
By Melissa McNulty, PhD, Professor of Nursing, October 2026.
